|
|
Article: New Product Launches Set to Unleash Multiple Growth Avenues in U.S. Monoclonal Antibodies Market.
- Article from:
- Business Wire
- Article date:
- June 9, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PALO ALTO, Calif. -- The U.S. therapeutic monoclonal antibodies market is poised for a quantum leap with the launch of a multitude of new products and vigorous expansion of therapeutic indications of existing products. A combination of these factors, along with high demand and lack of generic competition, expects to create exciting new possibilities and ensure continued market growth.
New analysis from Frost & Sullivan (http://www.pharma.frost.com), U.S. Biotechnology - Therapeutic Monoclonal Antibodies Market, finds the market earned revenues of over $12.61 billion in 2007 and estimates this to reach $34.47 billion in 2014.
If you are interested in a ...